Institutional Ownership Phathom Pharmaceuticals, Inc. (PHAT)
This table provides information about the institutional ownership of Phathom Pharmaceuticals, Inc. (PHAT). We have compiled data on the 138 institutions that hold shares in the stock, with a total of 60.5 Million shares, which have been reported (via 13F filing form) to have a value of $628 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
Aug 14, 2025 Q2 2025 |
12,466,489
shares
|
$129 Million
6.31% of portfolio
|
Q2 2025
Added 23.32%
|
|
|
Medicxi Ventures Management (Jersey) LTD
|
Jul 08, 2025 Q2 2025 |
7,464,572
shares
|
$77.5 Million
20.28% of portfolio
|
Q1 2024
Added 98.48%
|
|
|
Invesco Ltd.
Atlanta, GA |
Aug 13, 2025 Q2 2025 |
4,140,072
shares
|
$43 Million
0.01% of portfolio
|
Q2 2025
Added 13.4%
|
|
|
Carlyle Group Inc.
Washington, DC |
Aug 08, 2025 Q2 2025 |
3,496,808
shares
|
$36.3 Million
41.56% of portfolio
|
Q2 2023
Added 19.14%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
2,926,373
shares
|
$30.4 Million
0.0% of portfolio
|
Q2 2024
Added 6.59%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 11, 2025 Q2 2025 |
2,787,311
shares
|
$28.9 Million
0.0% of portfolio
|
Q2 2025
Added 0.31%
|
|
|
Ensign Peak Advisors, Inc
Salt Lake City, UT |
May 14, 2025 Q1 2025 |
2,514,284
shares
|
$26.1 Million
0.03% of portfolio
|
Q1 2025
Reduced 0.51%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Aug 14, 2025 Q2 2025 |
2,250,497
shares
|
$23.4 Million
0.01% of portfolio
|
Q2 2025
Added 330.01%
|
|
|
683 Capital Management, LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
2,105,000
shares
|
$21.8 Million
1.58% of portfolio
|
Q2 2025
Added 45.67%
|
|
|
Nea Management Company, LLC
Timonium, MD |
Aug 14, 2025 Q2 2025 |
1,960,169
shares
|
$20.3 Million
1.56% of portfolio
|
Q4 2023
Added 53.55%
|
|
|
Wasatch Advisors Inc
Salt Lake City, UT |
Aug 14, 2025 Q2 2025 |
1,461,895
shares
|
$15.2 Million
0.08% of portfolio
|
Q2 2025
Reduced 14.09%
|
|
|
Abingworth LLP
London, X0 |
Feb 10, 2023 Q4 2022 |
1,435,106
shares
|
$14.9 Million
5.34% of portfolio
|
Q1 2022
Added 19.28%
|
|
|
Catalys Pacific, LLC
Tokyo, M0 |
Aug 13, 2025 Q2 2025 |
1,167,114
shares
|
$12.1 Million
8.5% of portfolio
|
Q4 2024
Added 3.97%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 08, 2025 Q2 2025 |
1,069,927
shares
|
$11.1 Million
0.0% of portfolio
|
Q2 2025
Added 5.26%
|
|
|
Avidity Partners Management LP
Dallas, TX |
Aug 14, 2025 Q2 2025 |
1,064,500
shares
|
$11 Million
2.76% of portfolio
|
Q2 2025
Added 33.06%
|
|
|
Gw&K Investment Management, LLC
Boston, MA |
Aug 11, 2025 Q2 2025 |
1,048,472
shares
|
$10.9 Million
0.09% of portfolio
|
Q2 2025
Reduced 5.06%
|
|
|
Propel Bio Management, LLC
Los Angeles, CA |
Aug 13, 2025 Q2 2025 |
922,927
shares
|
$9.58 Million
10.74% of portfolio
|
Q2 2025
Reduced 18.68%
|
|
|
Decheng Capital Management Iii (Cayman), LLC
|
Nov 13, 2023 Q3 2023 |
850,000
shares
|
$8.82 Million
4.88% of portfolio
|
Q2 2023
New holding
|
|
|
State Street Corp
Boston, MA |
Aug 14, 2025 Q2 2025 |
849,424
shares
|
$8.82 Million
0.0% of portfolio
|
Q2 2025
Reduced 5.76%
|
|
|
Catalio Capital Management, LP
New York, NY |
Aug 14, 2025 Q2 2025 |
672,290
shares
|
$6.98 Million
1.35% of portfolio
|
Q2 2025
New holding
|
|
|
Moore Capital Management, LP
New York, NY |
Aug 14, 2025 Q2 2025 |
600,000
shares
|
$6.23 Million
0.08% of portfolio
|
Q2 2025
New holding
|
|
|
Simplify Asset Management Inc.
New York, NY |
Aug 07, 2025 Q2 2025 |
521,935
shares
|
$5.42 Million
0.29% of portfolio
|
Q2 2025
Reduced 23.46%
|
|
|
Citigroup Inc
|
Aug 11, 2025 Q2 2025 |
517,247
shares
|
$5.37 Million
0.0% of portfolio
|
Q2 2025
Reduced 2.56%
|
|
|
Eagle Asset Management Inc
St Petersburg, FL |
Nov 12, 2024 Q3 2024 |
455,196
shares
|
$4.72 Million
0.05% of portfolio
|
Q3 2024
Added 25.93%
|
|
|
Step Stone Group LP
La Jolla, CA |
Aug 13, 2025 Q2 2025 |
422,085
shares
|
$4.38 Million
10.14% of portfolio
|
Q3 2021
New holding
|